![Donna Parr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donna Parr
Directeur/Membre du Conseil chez
CONSTELLATION SOFTWARE INC.
Fortune : 385 201 $ au 31/05/2026
Profil
Donna Parr is currently Independent Director at Constellation Software, Inc. since 2020.
Director at ViOptix, Inc., Twinstrand Therapeutics, Inc., and Secretary & Director at CellAegis Devices, Inc. Independent Non-Executive Director at Topicus.com, Inc. and Non-Executive Director at Topicus.com BV since 2020.
President of Crimson Capital, Inc. since 2009.
Managing partner at Cross-Border Impact Ventures since 2019.
Former Director at Constellation Software, Inc. from 1995 to 2003.
Former Director at Adnavance Technologies, Inc. and Centurion Asset Management, Inc. Former Senior Vice President at MedTech Partners, Inc. Former Senior Vice President at Medical Discovery Management Corp.
from 2006 to 2009.
Education includes an MBA from York University conferred in 1982 and undergraduate and graduate degrees from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2026 | 99 ( 0 % ) | 202 752 $ | 31/05/2026 | |
| 02/04/2026 | 2 511 ( 0 % ) | 182 449 $ | 31/05/2026 |
Postes actifs de Donna Parr
| Sociétés | Poste | Début |
|---|---|---|
| CONSTELLATION SOFTWARE INC. | Directeur/Membre du Conseil | 02/06/2020 |
| TOPICUS.COM INC. | Directeur/Membre du Conseil | 01/01/2020 |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biological drugs | Directeur/Membre du Conseil | - |
CellAegis Devices, Inc.
 CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops device for the treatment of cardiac patients | Directeur/Membre du Conseil | - |
Crimson Capital, Inc.
 Crimson Capital, Inc. Financial ConglomeratesFinance Provides investment services | President | 01/01/2009 |
ViOptix, Inc.
 ViOptix, Inc. Medical SpecialtiesHealth Technology Develops tissue oximetry technology which enables non-invasive, direct and real-time measurement of local tissue oxygen saturation | Directeur/Membre du Conseil | - |
Topicus.com BV
 Topicus.com BV Packaged SoftwareTechnology Services Builds and manages vertical market software platforms | Directeur/Membre du Conseil | 01/01/2020 |
Cross-Border Impact Ventures
 Cross-Border Impact Ventures Investment ManagersFinance Cross-Border Impact Ventures invests in companies located in Canada. The firm focuses on the transformative health technology sector. It provide financing for early stage capital requirements. | Private Equity Investor | 01/05/2019 |
Anciens postes connus de Donna Parr
| Sociétés | Poste | Fin |
|---|---|---|
Centurion Asset Management, Inc.
 Centurion Asset Management, Inc. Investment ManagersFinance Provides investment advice | Directeur/Membre du Conseil | 01/03/2022 |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Donna Parr
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Constellation Software, Inc.
 Constellation Software, Inc. Packaged SoftwareTechnology Services Develops and installs software & provides professional services | Technology Services |
ViOptix, Inc.
ViOptix, Inc. Medical SpecialtiesHealth Technology Develops tissue oximetry technology which enables non-invasive, direct and real-time measurement of local tissue oxygen saturation | Health Technology |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adnavance Technologies, Inc.
 Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ultra-sensitive DNA technology solutions | Commercial Services |
MedTech Partners, Inc.
 MedTech Partners, Inc. Investment ManagersFinance MTP generally invests in research and technologies at an early stage of development, even prior to a full evaluation of commercial potential. Selection criteria include the potential size of the market, the credibility and efforts of the principal investigators, the uniqueness of the discovery and the patentability of the discovery. Investments are made by MTP or cover costs relating to patenting, demonstration of proof-of-principle, prototype development and market analysis. | Finance |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biological drugs | Health Technology |
Medical Discovery Management Corp.
 Medical Discovery Management Corp. Investment ManagersFinance Medical Discovery Management Corp. manages the Canadian Medical Discoveries Fund (CMDF), a venture capital fund focused on the health science sector including life sciences, biotechnology, diagnostics, medical devices, drug discovery and development, health care delivery services and e-health. The Fund invests in technologies and intellectual property that are significant in the global marketplace and focuses on businesses involved in the testing and development or production and commercialization stages of development which have significant potential for growth. CMDF seeks investments that will provide at least a 30% annualized return. Expected time horizon for a liquid market, merger or acquisition is 2 to 4 years | Finance |
Crimson Capital, Inc.
Crimson Capital, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops device for the treatment of cardiac patients | Electronic Technology |
Centurion Asset Management, Inc.
Centurion Asset Management, Inc. Investment ManagersFinance Provides investment advice | Finance |
Topicus.com, Inc.
 Topicus.com, Inc. Packaged SoftwareTechnology Services Develops vertical market software | Technology Services |
Topicus.com BV
Topicus.com BV Packaged SoftwareTechnology Services Builds and manages vertical market software platforms | Technology Services |
Cross-Border Impact Ventures
Cross-Border Impact Ventures Investment ManagersFinance Cross-Border Impact Ventures invests in companies located in Canada. The firm focuses on the transformative health technology sector. It provide financing for early stage capital requirements. | Finance |
